Abbott Laboratories (ABT) Inventory Average (2009 - 2026)

Abbott Laboratories has disclosed Inventory Average across 18 years of filings, most recently posting $6.7 billion for Q1 2026.

• Inventory Average for Q1 2026 came in at $6.7 billion, up 5.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.7 billion (up 5.02% YoY), and the FY2025 annual result was $6.3 billion, down 0.64% from the prior year.
• Inventory Average came in at $6.7 billion for Q1 2026 at Abbott Laboratories, up from $6.6 billion in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $6.8 billion in Q3 2025 to a low of $5.4 billion in Q1 2022.
• The 5-year median for Inventory Average is $6.6 billion (2023), against an average of $6.5 billion.
• Across the five-year window, Inventory Average advanced 18.42% in 2023 and declined 4.21% in 2025, its largest moves.
• Abbott Laboratories' Inventory Average stood at $6.0 billion in 2022, then grew by 11.03% to $6.6 billion in 2023, then declined by 1.61% to $6.5 billion in 2024, then grew by 1.45% to $6.6 billion in 2025, then grew by 2.13% to $6.7 billion in 2026.
• The last three Inventory Average figures came in at $6.7 billion (Q1 2026), $6.6 billion (Q4 2025), and $6.8 billion (Q3 2025), per Business Quant data.